The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

Latest News

Study: CT-Based AI Offers Enhanced Sensitivity and Reduced Segmentation Time for Lung Tumors
Study: CT-Based AI Offers Enhanced Sensitivity and Reduced Segmentation Time for Lung Tumors

January 21st 2025

Emerging research suggests that a deep learning model may offer 92 percent sensitivity in lung tumor detection on CT scans and up to a 59 percent reduction in tumor segmentation time.

Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging
Seven Takeaways from New CT and MRI Guidelines for Ovarian Cancer Staging

January 20th 2025

CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer

January 15th 2025

FDA Clears CT-Based AI Software for Enhanced Detection of Usual Interstitial Pneumonia
FDA Clears CT-Based AI Software for Enhanced Detection of Usual Interstitial Pneumonia

January 10th 2025

New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC

January 2nd 2025

Video Interviews
Latest CME Events & Activities

Annual Hawaii Cancer Conference

January 25-26, 2025

Register Now!

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

View More

Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®

View More

18th Annual New York GU Cancers Congress™

March 28-29, 2025

Register Now!

Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®

View More

Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

More News

© 2025 MJH Life Sciences

All rights reserved.